Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing?

byiShook Opinion
Nov 7, 2024 - 08:15

Share

Moderna crushed third-quarter views on Thursday and turned around a surprise profit, but Moderna stock could slump on light RSV vaccine sales. The post Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing? appeared first on Investor's Business Daily.

Moderna crushed third-quarter views on Thursday and turned around a surprise profit, but Moderna stock could slump on light RSV vaccine sales.

The post Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing? appeared first on Investor's Business Daily.